top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teleflex Incorporated Common Stock (NY:TFX)

129.44 +1.22 (+0.95%)
Delayed Quote Updated: 10:14 AM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
These Analysts Cut Their Forecasts On Teleflex Following Q3 Results ↗
 
Via Benzinga
News headline image
Why Teleflex (TFX) Stock Is Falling Today
Shares of medical technology company Teleflex (NYSE:TFX) fell 15.5% in the morning session after the company reported underwhelming earnings. The medical technology firm's operating margin collapsed to... 
Via StockStory
Topics Artificial Intelligence Economy Government
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Teleflex (NYSE:TFX) Q3 Earnings Beat Estimates Amid Impairment Charges and Mixed Outlook ↗
Teleflex posted strong Q3 revenue and beat EPS estimates, but faces headwinds from impairment charges and a mixed full-year outlook. 
Via Chartmill
Topics Earnings
News headline image
Teleflex’s (NYSE:TFX) Q3 Sales Top Estimates
Medical technology company Teleflex (NYSE:TFX) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 19.4% year on year to $913 million. Its non-GAAP profit of $3.67 per... 
Via StockStory
News headline image
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex (TFX) Q3 Earnings: What To Expect
Medical technology company Teleflex (NYSE:TFX) will be reporting results this Thursday morning. Here’s what to look for. 
Via StockStory
News headline image
1 Safe-and-Steady Stock Worth Investigating and 2 Facing Challenges
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
News headline image
Teleflex Inc (NYSE:TFX) Presents a Compelling Case for Value Investors ↗
Discover Teleflex Inc (TFX), an undervalued stock with strong financials, solid profitability, and a low P/E ratio, offering a potential margin of safety for value investors. 
Via Chartmill
News headline image
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
News headline image
Why Teleflex (TFX) Stock Is Trading Lower Today
Shares of medical technology company Teleflex (NYSE:TFX) fell 5.4% in the afternoon session after the U.S. government launched a probe into the medical device industry. 
Via StockStory
Topics Artificial Intelligence
News headline image
Teleflex Inc (NYSE:TFX) Screened as a Potential Value Investment with Strong Fundamentals ↗
Teleflex Inc (TFX) appears undervalued with a low P/E ratio, strong profitability, solid financial health, and positive growth forecasts, making it a compelling stock for value investors. 
Via Chartmill
News headline image
A Look Back at Surgical Equipment & Consumables - Specialty Stocks’ Q2 Earnings: Teleflex (NYSE:TFX) Vs The Rest Of The Pack
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at surgical equipment & consumables -... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents 
From Teleflex Incorporated
Via GlobeNewswire
News headline image
1 Safe-and-Steady Stock on Our Buy List and 2 We Find Risky
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
News headline image
3 Cash-Producing Stocks Walking a Fine Line
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
News headline image
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
News headline image
Teleflex Inc. (NYSE:TFX) Emerges as a Top Value Stock with Strong Fundamentals ↗
Discover Teleflex Inc. (TFX), an undervalued medical tech stock with strong fundamentals, solid profitability, and a compelling valuation for value investors. 
Via Chartmill
News headline image
1 Healthcare Stock Worth Investigating and 2 Facing Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
News headline image
Buy, Sell, or Hold? Insiders Pile Into These 3 Healthcare Stocks ↗
Insiders are buying stocks like LLY, TFX, and CALC. The question is whether they are also a good buy for investors, and not all of them are. 
Via MarketBeat
News headline image
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
From Teleflex Incorporated
Via GlobeNewswire
News headline image
TFX Q2 Deep Dive: Interventional Growth and Strategic Portfolio Shifts Define Outlook
Medical technology company Teleflex (NYSE:TFX) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.3% year on year to $780.9 million. Its non-GAAP profit of $3.73 per share was 10.8%... 
Via StockStory
Topics World Trade
News headline image
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
News headline image
3 Value Stocks with Questionable Fundamentals
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
News headline image
Teleflex Inc (NYSE:TFX) Recognized as a Strong Value Investment with Solid Fundamentals ↗
Teleflex Inc (NYSE:TFX) is a solid value stock with strong profitability, reasonable valuation, and stable financials, offering a potential safety net for investors. 
Via Chartmill
News headline image
Deep Dive Into Teleflex Stock: Analyst Perspectives (7 Ratings) ↗
 
Via Benzinga
News headline image
Teleflex Inc (NYSE:TFX) Beats Q2 2025 Earnings Estimates with Strong Revenue and EPS Growth ↗
Teleflex (NYSE:TFX) beats Q2 2025 estimates with $780.9M revenue and $3.73 EPS, driving a 15.9% pre-market surge. Strong growth in medical tech sector. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page